Literature DB >> 26984246

The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy.

Bethany D Nugent1, Susan M Sereika1, Margaret Rosenzweig1, Michael McCue2, John D Merriman1, Catherine M Bender3.   

Abstract

PURPOSE: Previous research has explored occupational activity of breast cancer survivors but has not examined the influence of occupational level on symptoms prospectively. The purpose of this study was to examine the relationship between occupational classification and changes in mood and symptom burden for postmenopausal breast cancer survivors during the first year of anastrozole therapy.
METHODS: This was an exploratory secondary analysis in 49 postmenopausal women receiving anastrozole therapy for early-stage breast cancer. Participants reported their occupation at baseline and completed self-report questionnaires measuring mood and symptom burden at baseline, 6 months, and 12 months. Occupation was classified according to four major skill levels delineated by the International Standard Classification of Occupations (ISCO).
RESULTS: Breast cancer survivors employed at occupational skill levels 1 through 3 reported significantly higher depressive symptoms, fatigue, and total symptoms on average than those employed at ISCO skill level 4. After adjusting for multiple comparisons, this pattern remained for the musculoskeletal, vasomotor, and gastrointestinal symptom subscales.
CONCLUSIONS: Breast cancer survivors employed at lower skill levels (i.e., ISCO 1-3) reported poorer mood and greater symptom burden than breast cancer survivors employed at a higher skill level (i.e., ISCO 4). Assessing baseline occupation of occupationally active breast cancer survivors may improve understanding of the association between types of occupations and mood and symptom trajectories and may inform development of interventions to mitigate symptom severity in order to help breast cancer survivors maintain optimal occupational function and adherence to therapy.

Entities:  

Keywords:  Anastrozole therapy; Breast cancer survivors; Cognitive function; Employment; Occupational skill

Mesh:

Substances:

Year:  2016        PMID: 26984246      PMCID: PMC4919126          DOI: 10.1007/s00520-016-3161-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  25 in total

1.  A qualitative study of work and work return in cancer survivors.

Authors:  Deborah S Main; Carolyn T Nowels; Tia A Cavender; Martine Etschmaier; John F Steiner
Journal:  Psychooncology       Date:  2005-11       Impact factor: 3.894

2.  The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.

Authors:  Annette L Stanton; Coen A Bernaards; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2005-03-16       Impact factor: 13.506

3.  Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.

Authors:  A Buzdar; A Howell; J Cuzick; C Wale; W Distler; G Hoctin-Boes; J Houghton; G Y Locker; J M Nabholtz
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

Review 4.  Factors reported to influence the return to work of cancer survivors: a literature review.

Authors:  Evelien R Spelten; Mirjam A G Sprangers; Jos H A M Verbeek
Journal:  Psychooncology       Date:  2002 Mar-Apr       Impact factor: 3.894

Review 5.  Factors affecting cancer survivors' employment and work ability.

Authors:  T Taskila; M L Lindbohm
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

Review 6.  The economic burden of depression with painful symptoms.

Authors:  Paul E Greenberg; Stephanie A Leong; Howard G Birnbaum; Rebecca L Robinson
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

7.  Breast cancer survivors at work.

Authors:  Jennifer A Hansen; Michael Feuerstein; Lisseth C Calvio; Cara H Olsen
Journal:  J Occup Environ Med       Date:  2008-07       Impact factor: 2.162

8.  The role of neuropsychological functioning in cancer survivors' return to work one year after diagnosis.

Authors:  Karen Nieuwenhuijsen; Angela de Boer; Evelien Spelten; Mirjam A G Sprangers; Jos H A M Verbeek
Journal:  Psychooncology       Date:  2009-06       Impact factor: 3.894

9.  Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use.

Authors:  Katherine L Kahn; Eric C Schneider; Jennifer L Malin; John L Adams; Arnold M Epstein
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

10.  Workplace support for employees with cancer.

Authors:  B Nowrouzi; N Lightfoot; K Cote; R Watson
Journal:  Curr Oncol       Date:  2009-09       Impact factor: 3.677

View more
  1 in total

1.  Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer.

Authors:  Catherine M Bender; John D Merriman; Susan M Sereika; Amanda L Gentry; Frances E Casillo; Theresa A Koleck; Margaret Q Rosenzweig; Adam M Brufsky; Priscilla McAuliffe; Yehui Zhu; Yvette P Conley
Journal:  Oncol Nurs Forum       Date:  2018-05-01       Impact factor: 2.172

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.